These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Use of a platelet anti-aggregant in evolutive glomerular nephropathies associated with regional intravascular coagulation disorder]. Mioli V; Ragaiolo M; Figus S; Foglia A; Sprovieri G Clin Ter; 1978 Aug; 86(3):249-61. PubMed ID: 33779 [No Abstract] [Full Text] [Related]
24. [Recent aspects of the coagulation process, circumstances for its influencing by drugs]. Montigel C Zentralbl Phlebol; 1968 Feb; 7(1):83-8. PubMed ID: 5682818 [No Abstract] [Full Text] [Related]
25. Platelet aggregation and the platelet release reaction in thromboembolism. Mustard JF; Packham MA Can Med Assoc J; 1970 Oct; 103(8):859-63. PubMed ID: 5476316 [No Abstract] [Full Text] [Related]
27. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor]. Satake K Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626 [No Abstract] [Full Text] [Related]
28. [Long-acting fibrinolytic drugs. Drugs acting on platelet aggregation]. de Nicola P Angeiologie; 1967; 20():Suppl:45-53. PubMed ID: 5621507 [No Abstract] [Full Text] [Related]
29. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats. Renaud S; Lecompte F Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948 [No Abstract] [Full Text] [Related]
30. [Contribution to the diagnostic and prognostic value of tests for blood lipid disorders, coagulation disorders and thrombocyte adhesiveness in cerebral vascular disorders]. Popoviciu L; Pascu I; Waitsuk P; Gáspár S; Palade C; Dulău E; Brendus E Stud Cercet Neurol; 1969; 14(1):57-65. PubMed ID: 5823324 [No Abstract] [Full Text] [Related]
31. [Hopes, joys and disappointments of surgeons in connection with the development of the blood coagulation problem]. Filatov AN Vestn Khir Im I I Grek; 1969 Aug; 103(8):3-10. PubMed ID: 5397112 [No Abstract] [Full Text] [Related]
32. [Resuscitation of patients with high risk of hemorrhage and thromboembolism. Biological supervision. Indications of controlled heparin therapy]. Boneu B; Cathala B; Jorda MF; Bierme R; Lareng L Nouv Presse Med; 1972 Jan; 1(1):29-32. PubMed ID: 5061187 [No Abstract] [Full Text] [Related]
33. [Blood coagulation changes and pathogenesis of diabetic retinopathy. Recent advances]. Porta M; Nuzzi R; Passera P Minerva Med; 1984 Oct; 75(41):2407-20. PubMed ID: 6390258 [TBL] [Abstract][Full Text] [Related]
35. [Drug information: coagulation inhibiting drugs. III, Thrombocyte function inhibiting drugs]. Veje JO Sygeplejersken; 1981 Aug; 81(30):14. PubMed ID: 6913201 [No Abstract] [Full Text] [Related]
36. The status of new anticoagulants. Bates SM; Weitz JI Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562 [TBL] [Abstract][Full Text] [Related]
37. Biochemistry and physiology of blood platelets. Holmsen H; Day HJ Ann Clin Lab Sci (1971); 1971; 1(1):38-47. PubMed ID: 5161281 [No Abstract] [Full Text] [Related]
38. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment]. Syrjälä M Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922 [No Abstract] [Full Text] [Related]